Novo Nordisk A/S (CPH:NOVO.B)
Denmark · Delayed Price · Currency is DKK 272.00
-11.85 (-4.17%)
Jun 8, 2026, 4:59 PM CET
Novo Nordisk Market Cap
Novo Nordisk has a market cap or net worth of 1.26 trillion as of June 8, 2026. Its market cap has decreased by -34.51% in one year.
Market Cap
1.26T
Enterprise Value
1.38T
Revenue
327.80B
Ranking
n/a
PE Ratio
10.36
Stock Price
272.00
Market Cap Chart
Since February 18, 1997, Novo Nordisk's market cap has increased from 46.00B to 1.26T, an increase of 2,635.23%. That is a compound annual growth rate of 11.95%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 4, 2026 | 1.26T | -12.94% |
| Dec 30, 2025 | 1.45T | -47.87% |
| Dec 30, 2024 | 2.77T | -10.93% |
| Dec 29, 2023 | 3.11T | 46.89% |
| Dec 30, 2022 | 2.12T | 26.50% |
| Dec 30, 2021 | 1.67T | 69.77% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Genmab | 97.22B |
| Coloplast | 86.40B |
| ALK-Abelló | 58.98B |
| Demant | 53.19B |
| H. Lundbeck | 42.96B |
| Zealand Pharma | 22.92B |
| Ambu A/S | 17.48B |
| Bavarian Nordic | 13.97B |